IRRAS
Develops innovative fluid exchange & ICP monitoring systems for neurocritical care patients.
IRRAS | ST
Overview
Corporate Details
- ISIN(s):
- SE0008321202
- LEI:
- 549300EKKVQN2J25MJ59
- Country:
- Sweden
- Address:
- VASAGATAN 16, 111 20 Stockholm
- Website:
- https://irras.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
IRRAS is a global, commercial-stage medical device company that develops and commercializes innovative solutions for neurocritical care. The company focuses on addressing conditions such as traumatic brain injuries and hemorrhagic strokes. Its flagship product, the IRRAflow system, is an advanced fluid exchange and intracranial pressure monitoring technology that combines controlled irrigation with drainage. IRRAS aims to transform patient outcomes, improve the standard of care for critically ill patients, and reduce the overall cost of treatment through its portfolio of neurocritical care products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-20 17:46 |
Delisting Announcement
IRRAS’s application for delisting has been approved and the Board of Directors …
|
English | 126.4 KB | ||
| 2023-10-20 17:46 |
Delisting Announcement
IRRAS ansökan om avnotering har godkänts och styrelsen har fattat beslut om att…
|
Swedish | 125.5 KB | ||
| 2023-10-20 00:06 |
Pre-Annual General Meeting Information
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB
|
English | 172.4 KB | ||
| 2023-10-20 00:06 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB
|
Swedish | 186.8 KB | ||
| 2023-10-16 18:30 |
Prospectus
IRRAS publishes prospectus
|
English | 1.7 MB | ||
| 2023-10-16 18:30 |
Prospectus
IRRAS offentliggör prospekt
|
Swedish | 1.7 MB | ||
| 2023-10-16 13:14 |
Major Shareholding Notification
|
English | 35.3 KB | ||
| 2023-10-15 21:45 |
Capital/Financing Update
IRRAS has extended maturity date for its SEK 20 million short-term loan
|
English | 71.9 KB | ||
| 2023-10-15 21:45 |
Capital/Financing Update
IRRAS har senarelagt förfallodagen för dess kortfristiga lån om SEK 20 miljoner
|
Swedish | 86.6 KB | ||
| 2023-10-13 18:00 |
Share Issue/Capital Change
Kommuniké från extra bolagsstämma i IRRAS AB (publ) den 13 oktober 2023
|
Swedish | 104.6 KB | ||
| 2023-10-13 18:00 |
Share Issue/Capital Change
Bulletin from the Extraordinary General Meeting in IRRAS AB (publ) on 13 Octobe…
|
English | 138.2 KB | ||
| 2023-09-18 20:31 |
Share Issue/Capital Change
Statement by the Board of Directors of IRRAS AB
|
English | 201.2 KB | ||
| 2023-09-18 20:30 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB (PUBL)
|
Swedish | 187.2 KB | ||
| 2023-09-15 08:00 |
Capital/Financing Update
IRRAS säkrar utökad bryggfinansiering
|
Swedish | 186.1 KB | ||
| 2023-09-15 08:00 |
Capital/Financing Update
IRRAS Secures Extended Short-Term Loan Agreement
|
English | 157.8 KB |
Automate Your Workflow. Get a real-time feed of all IRRAS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for IRRAS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-13 | Marios Fotiadis | Other | Other | 338,264,840 | 60,887,671.20 SEK |
| 2023-09-18 | Marios Fotiadis | Other | Buy | 9,185,346 | 1,653,362.28 SEK |
| 2023-09-04 | MARIOS FOTIADIS | Other | Sell | 1,277,700 | 229,986.00 SEK |
| 2021-06-11 | Bacara Holdings Limited | Other | Other | 3,500,000 | 17,500,000.00 SEK |
| 2021-06-11 | Kleanthis Xanthopoulos | Other | Other | 200,000 | 1,000,000.00 SEK |
| 2021-05-04 | Sabina Berlin | Other | Buy | 8,532 | 49,997.52 SEK |
| 2020-09-24 | Carl Martin | Other | Buy | 14,859 | 99,950.55 SEK |
| 2020-09-22 | Carl Martin | Other | Buy | 5,141 | 33,365.09 SEK |
| 2020-04-09 | Anders Paul Wiklund | Other | Other | 17,134 | 99,377.20 SEK |
| 2020-04-09 | Sabina Berlin | Other | Other | 7,280 | 42,224.00 SEK |
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
